Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 250

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment

Open access
Vijayan, Anitha, Faubel, Sarah, Askenazi, David J., Cerda, Jorge, Fissell, William H., Heung, Michael, Humphreys, Benjamin D., Koyner, Jay L., Liu, Kathleen D., Mour, Girish, Nolin, Thomas D., Bihorac, Azra, Faubel, Sarah, Askenazi, David J., Basu, Rajit K., Bhatt, Udayan Y., Bihorac, Azra, Cerda, Jorge, Connor, Michael J., Davidson, Alan J., de Caestecker, Mark P., Doi, Kent, Fissell, William H., Golestaneh, Ladan, Heung, Michael, Humphreys, Benjamin D., Koyner, Jay L., Liu, Kathleen D., Mour, Girish K., Singh, Prabhleen, Thakar, Charuhas V., Vijayan, Anitha · 2016 · American Journal of Kidney Diseases

Abstract

Acute kidney injury (AKI) is a devastating complication commonly occurring in the critically ill population with devastating short- and long-term consequences. Despite standardization of the definition and staging of AKI, early recognition remains challenging given that serum creatinine (Scr) is a marker—albeit imperfect—of kidney function and not kidney injury. Furthermore, the delay in rise of Scr after loss of glomerular filtration also prevents timely detection of decreased kidney function in patients with AKI. Over the past decade, numerous clinical investigations have evaluated the utility of several biomarkers in the early diagnosis and risk stratification of AKI. In 2014, the US Food and Drug Administration (FDA) approved the marketing of a test based on the combination of the urine concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7 ([TIMP-2]x[IGFBP7]) to determine if certain critically ill patients are at risk of developing moderate to severe AKI. The optimal role of this biomarker in diagnosis, management, and prognosis of AKI in different clinical settings requires further clarification. In this perspective, we summarize the biological actions of these two cell-cycle arrest biomarkers, and present important considerations regarding the clinical application, interpretation, and limitations of this novel test for the early detection AKI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2015.12.033

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 250

Metadata

Authors
Vijayan, A., Faubel, S., Askenazi, D. J., Cerda, J., Fissell, W. H., Heung, M., Humphreys, B. D., Koyner, J. L., Liu, K. D., Mour, G., Nolin, T. D., Bihorac, A., Faubel, S., Askenazi, D. J., Basu, R. K., Bhatt, U. Y., Bihorac, A., Cerda, J., Connor, M. J., Davidson, A. J., de Caestecker, M. P., Doi, K., Fissell, W. H., Golestaneh, L., Heung, M., Humphreys, B. D., Koyner, J. L., Liu, K. D., Mour, G. K., Singh, P., Thakar, C. V., & Vijayan, A.
Venue
American Journal of Kidney Diseases
Publisher
Elsevier BV
Published
2016-07
Volume
68
Issue
1
Pages
19-28
ISSN
0272-6386 (ISSN-L)
OpenAlex
W2289115148
Cited by
250
References
1
FWCI
22.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.